Aim: To study the functional dyspepsia in chronic hemodialysis patients of CNHU-HKM of Cotonou. Methods: This descriptive, analytical and cross-sectional study ran from 1 September 2013 to 28 February 2014 in the University Clinic of Nephrology Dialysis of CNHU-HKM of Cotonou. It included all chronic renal failure patients on hemodialysis for at least 9 months prior to the survey. After identifying the patients with upper gastrointestinal disorders, we had submitted to clinical Rome III criteria for functional dyspepsia. Upper endoscopy was performed in patients with clinical criteria of functional dyspepsia. Clinical factors associated, paraclinical and therapeutic were sought by logistic regression in univariate analysis. Data were analyzed using EPI DATA version 3.1. Results: 1) One hundred and thirty-one haemodialysis patients had participated in the study (sex ratio: 1.5, average age 49.6 ± 12.4 years). 2) The prevalence was 71.8% for upper gastrointestinal disorders, 64.9% for dyspeptic syndrome and 1.5% for functional dyspepsia. 3) They were associated to clinical criteria of functional dyspepsia of Roma III, the presence of high blood pressure, hypocalcaemia, treatment with calcic inhibitors and iron supplementation. Conclusion: Functional dyspepsia is uncommon in hemodialysis. The search of an organic cause is imperative for every dyspepsia.
References
[1]
Peyrin-Biroulet, L. and Bigard, M.A. (2005) Dyspepsie. EMC-Hépato-Gastroentérologie, 2, 105-123. http://dx.doi.org/10.1016/j.emchg.2005.01.003
[2]
Avram, M.M., Fein, P.A., Rafiq, M.A., Scholth, T., Chattopad-Hyay, J. and Mittman, N. (2006) Malnutrition and Inflammation as Predictors of Mortality in Peritoneal DIALYSIS Patients. Kidney International Supplements, 104, 4-7.
[3]
Olomos, J.A., Pogorelsky, V., Tobal, F., Marcolongo, M., Salis, G., Higa, R., et al. (2006) Uninvestigated Dyspepsia in Latin America: A Population-Based Study. Digestive Diseases and Sciences, 51, 1922-1929. http://dx.doi.org/10.1007/s10620-006-9241-y
[4]
Tougas, G., Hwang, P. and Paterson, W.G. (1998) Dyspeptic Symptoms in the General Canadian Population: Prevalence and Impact on Quality of Life. Gastro-Enterology, 114, A312. http://dx.doi.org/10.1016/S0016-5085(98)81265-1
[5]
Shaib, Y. and El-Serag, H.B. (2004) The Prevalence and Risk Factors of Functional Dyspepsia in Multiethnic Population in the United States. The American Journal of Gastroenterology, 99, 2210-2216. http://dx.doi.org/10.1111/j.1572-0241.2004.40052.x
[6]
Moayyedi, P. and Masson, J. (2002) Clinical and Economic Consequences of Dyspepsia in the Community. Gut, 50, 10-12. http://dx.doi.org/10.1136/gut.50.suppl_4.iv10
[7]
Humair, J.P., Stalder, H. and Armenian, B. (2002) Dyspepsie. Primary Care, 2, 459-467.
Sossa, B.R. (2007) Aspects cliniqueset socio-économiques de la dyspepsie à Cotonou. Thèse de Médecine FSS, Cotonou, No. 1380, 104.
[10]
Li, Y., Nie, Y., Sha, W. and Su, H. (2002) The Link between Psychosocial Factors and Functional Dyspepsia: An Epidemiological Study. CMJ, 115, 1082-1084.
[11]
Mbengue, M., Diouf, M., Ka, M., Dangou, J.M., Ba-Seck, A., Ndiaye, M.F., et al. (1998) Dyspepsie fonctionnelle et Hélicobacter pylori à Dakar. Médecine d’Afrique Noire, 45, 386-388.
[12]
Chong, V.H. and Tan, J. (2013) Prevalence of Gastrointestinal and Psychosomatic Symptoms among Asian Patients Undergoing Regular Hemodialysis. Nephrology, 18, 97-103. http://dx.doi.org/10.1111/nep.12000
[13]
El-Filali, E.H., Layine, A., Aimad, I., Zamd, M., Medkouri, G., Hachim, K., et al. (2009) Manifestations digestives hautes chez les patients hémodialysés chroniques. Nephrologie et thérapeutique, 5, 436-471.
[14]
Strid, H., Fjell, A., Simren, M. and Bjornsson, E.S. (2009) Impact of Dialysis on Gastroesophageal Reflux, Dyspepsia, and Proton Pump Inhibitor Treatment in Patients with Chronic Renal Failure. European Journal of Gastroenterology & Hepatology, 21, 137-142. http://dx.doi.org/10.1097/MEG.0b013e3283200047
[15]
Chong, V.H. (2010) Impact of Duration of Hemodialysis on Gastrointestinal Symptoms in Patients with End Stage Renal Failure. Journal of Gastrointestinal and Liver Diseases, 19, 462-463.
[16]
Elhoussni, S., Sabri, S., Mouram, H., Loko, S., Daoudi, F.Z., Errebih, H., et al. (2011) Apport de la fibroscopie oesogastroduodénale chez l’hémodialysé chronique. Néphrologie & Thérapeutique, 7, 411-447. http://dx.doi.org/10.1016/j.nephro.2011.07.357
[17]
Bruley des Varannes, S. (2011) Prise en charge de la Dyspepsie fonctionnelle. Post’U FMC-HGE, 65-74.
[18]
Held, P.J., Port, F.K., Wolfe, R.A., Stannard, D.C., Carroll, C.E., Daugirdas, J.T., Bloembergen, W.E., Greer, J.W. and Hakim, R.M. (1996) The Dose of Hemodialysis and Patient Mortality. Kidney International, 50, 550-556. http://dx.doi.org/10.1038/ki.1996.348
[19]
Bacci, M.R. and Chehter, E.Z. (2013) Dyspepsia among Patients with Chronic Kidney Disease: A Cross Sectional Study. International Archives of Medicine, 6, 43. http://dx.doi.org/10.1186/1755-7682-6-43
[20]
Combes, A. (2005) Inhibiteurs calciques et dérives nitrés La Collection Hippocrate ECN CARDIO PHARMACO: 2-3.
[21]
Soubai, R.B., Abourazzak, F.E. and Harzy, T. (2012) Hypocalcemie: Mise au point pratique. Revue Marocaine de Rhumatologie, 21, 4-9.
[22]
Salles Junior, L.D., Santos, P.R., dos Santos, A.A. and de Souza, M.H.L. (2013) Dyspepsia and Gastric Emptying in End-Stage Renal Disease Patients on Haemodialysis. BMC Nephrology, 14, 275. http://dx.doi.org/10.1186/1471-2369-14-275
[23]
Altay, M., Turgut, F., Akay, H., Kanbay, M., Babali, A., Akcay, A., et al. (2008) Dyspepsia in Turkish Patients on Continuous Ambulatory Peritoneal Dialysis. International Urology and Nephrology, 40, 211-217. http://dx.doi.org/10.1007/s11255-007-9324-5
[24]
Bradette, M. (2002) L’approche de la dyspepsie. Le Médecin du Québec, 37, 43-52.
